Showing posts with label Continued Process Verification. Show all posts
Showing posts with label Continued Process Verification. Show all posts

Tuesday, September 30, 2014

Continued Process Monitoring to Predict Product Variation

Today, we feature another one of our exclusive interviews from a BioProcess International Speaker.  Today we look to Pawel Drapala, Ph.D., Senior Process Engineer, Technical Manufacturing Services, Alexion Pharmaceuticals, Inc. who goes in depth on how process monitoring can be used not only to pass inspections but also ensure the identity, purity and strength of products but also to predict and avoid deviation in products.


Dr. Drapala will present Strategies for Continued Process Monitoring of Commercial Cell Culture and Purification at Large Scale on Thursday, October 23 at BioProcess International Conference and Exhibition.  Don't forget that as a reader of this blog, when you register to join us and mention priority code BPI14BLOG, you can save 20% off the standard rate.


Share this article with your social network, just click below to share now!


Friday, June 27, 2014

BPI Spotlight: BPOG Strategic Workstreams: Progress and Industry Updates

This fall at BioProcess International, we're pleased to announce that The BioPhorum Operations Group (BPOG) will be joining us to discuss the trends and challenges in the manufacturing industry.  The work group, which includes over 500 representatives and 18 member companies, will have a workshop at this year's event.

What sessions can you look forward to?
  • -Capacity, Technology and Innovation Trends in a High Variety Product Portfolio World
    • >Simon Chalk, Director, BioPhorum Operations Group (BPOG), United Kingdom
  • -Reflecting cGMP Requirements down the SUS Supply Chain
    • >Tony White, Director, BioPhorum Operations Group (BPOG), United Kingdom
  • -Continued Process Verification: A Model Plan Based on Cross-Industry Knowledge 
    • >Bert Frohlich, Ph.D., Director of Bioengineering, Shire Microbiological 
  • -Monitoring for Biological Drug Substance Manufacturing - An Industry Perspective 
    • >David Bain, Ph.D., Facilitator, BioPhorum Operations Group (BPOG), United Kingdom 
  • -Raw Material Variability: The Need for Supply Chain Collaboration, Transparency and Mutually Beneficial Relationships 
    • >Matthew Muldoon, Sourcing Manager, Strategic Sourcing Raw Materials & Medical Devices, Bayer HealthCare LLC
Also, at the end of the day, we'll have a panel discussion with all join to go over many of the highlights of the day  and reflect on questions including: Mapping the inbound material supply chain through multiple levels of interdependent suppliers; Achieving consistent understanding and application of new approaches that will be under regulatory scrutiny and How to rapidly ascertain industry best practice and implement successfully?

Want to join this Biophorum Operations Group session?  It will take place on Tuesday, October 21 in Boston at the BioProcess International Event.  Find out more about these sessions and the rest of the program by downloading the agenda.  As a reader of this blog, when you register to join us and mention code BPI14BLOG, you can save 20% off the standard rate. Have an questions?  Reach out to Jennifer Pereira.



Share this article with your social network, just click below to share now!